December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Digenic Inheritance of Early Onset Glaucoma: CYP1B1 a Potential Modifier Gene
Author Affiliations & Notes
  • AL Vincent
    Ophthalmology The Hospital for Sick Children Toronto ON Canada
  • G Billingsley
    Vision Science Research Program University Health Network University of Toronto Toronto ON Canada
  • A Levin
    Ophthalmology The Hospital for Sick Children Toronto ON Canada
  • Y Buys
    Ophthalmology The Toronto Western Hospital University Health Network Toronto ON Canada
  • M Priston
    Vision Science Research Program University Health Network University of Toronto Toronto ON Canada
  • D Williams-Lynn
    Vision Science Research Program University Health Network University of Toronto Toronto ON Canada
  • G Trope
    Ophthalmology The Toronto Western Hospital University Health Network Toronto ON Canada
  • E Heon
    Vision Science Research Program University Health Network University of Toronto Toronto ON Canada
  • Footnotes
    Commercial Relationships   A.L. Vincent, None; G. Billingsley, None; A. Levin, None; Y. Buys, None; M. Priston, None; D. Williams-Lynn, None; G. Trope, None; E. Heon, None. Grant Identification: Support: Glaucoma Trust of NZ
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3013. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      AL Vincent, G Billingsley, A Levin, Y Buys, M Priston, D Williams-Lynn, G Trope, E Heon; Digenic Inheritance of Early Onset Glaucoma: CYP1B1 a Potential Modifier Gene . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3013.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Define the role of MYOC, CYP1B1 and PITX2 in patients with juvenile open angle glaucoma. Methods: We undertook mutational analysis of three glaucoma-related genes (MYOC, CYP1B1 and PITX2)using a combination of single strand conformation polymorphism (SSCP), and direct cycle sequencing. The patient population included 60 unrelated cases affected with JOAG or early onset glaucoma (onset age 5-40 years). Results: MYOC mutations were identified in 8/60 individuals (13.3%); CYP1B1 mutations in 3/60 (5%) and none in PITX2. Individuals with MYOC mutations showed greater phenotypic variability than expected, and included pigment dispersion syndrome and a mixed-mechanism glaucoma. Mutations in CYP1B1 were identified in three cases that did not have features suggestive of congenital glaucoma. Study of one large pedigree with autosomal dominant glaucoma demonstrated segregation of both MYOC and CYP1B1 mutations with the disease. Those who carried the MYOC mutation alone had an average age of onset of 51 years (range 48-64), whereas carriers of both MYOC and CYP1B1 mutations had an average age of onset of 27 years ( range 23 - 38 years) (p= 0.001). Conclusion: This work supports the important role of MYOC in JOAG, but further demonstrates the variability of expression of this gene, as well as the genetic heterogeneity of juvenile glaucoma. We also propose that CYP1B1 may act as a modifier of MYOC expression, and the two genes may interact via a common pathway.

Keywords: 420 genetics • 480 mutations • 528 proteins encoded by disease genes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×